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Abstract 
Retinoic acid (RA) and butyric acid (BA) were 
investigated for their effect on in vitro migration of 
highly metastatic murine B16a meTanoma cells. These 
potential antitumor agents are known to alter the 
cytoskeleton. Our initial studies determined the 72 h 
cytostatic /c5totoxic concentration of RA (1 X 10-6 M I> 1 X 10- M) and BA (1.5 mM) / > 2.0 mM). Cy-
tostasis by RA and BA was confirmed by autoradio-
graphy and radioisotope incorporation. For migration 
assays, cells were plated on 3 and 5 µm diameter 
pore polycarbonate membranes. Complete media was 
added containing RA or BA at time of plating. For 
BA pretreatment studies, BA was added to cells for 
72 h prior to plating cells in fresh BA on the mem-
branes. Top and bottom surfaces of the membranes 
were examined after 72 h of incubation by scanning 
electron microscopy. Al though RA and BA induced 
cells on top of the membrane to change morphology 
as shown by phase, transmission and scanning elec-
tron microscopy, only BA enhanced the deformability 
of cells to allow for passage through the 3 µm dia-
meter pores. Butyric acid enhanced migration 
through 3 µm diameter pore membranes by 511%. 
For 5 µm diameter pore membranes, 55.2% of the 
plated number of untreated early passage cells migra-
ted to the bottom surface as compared to 5 7. 3 % for 
BA-treated cells and 14.9% for RA-treated cells. 
However, if cellular proliferation over the 72 h pe-
riod was factored in, BA increased migration by 456% 
over the controls and pretreatment of cells with BA 
for 72 h prior to plating increased migration by 
893%. Without considering proliferation, RA inhibited 
migration by 75% over controls. The decrease in mi-
gration observed in RA-treated cells was due to an 
inhibitory effect on cellular migration and a decrease 
in proliferation. 
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Introduction 
Progress in the treatment of cancer has been 
hampered by the inherent ability of tumor cells to 
metastasize. Metastasis is a complex, multi-step pro-
cess that is poorly understood. Tumor cells must in-
vade the extracellular matrix (ECM) at multiple 
stages during the metastatic process. Tumor cell in-
vasion of the ECM has been proposed to be a three 
step process: (1) attachment to endothelial cells and 
the ECM, (2) proteolytic digestion of the ECM, and 
(3) locomotion (Liotta et al., 1983). Although the 
role of tumor cell locomotion in invasion and metas-
tasis has been studied (Werling et al., 1986; Raz and 
Ben-Ze'ev, 1987; Maslow, 1987; Verschueren et al., 
1988), the specific step of migration needs to be 
clearly distinguished from the overall process of 
metastasis (Grimstad, 1987, 1988). 
The modified Boyden chamber has been a major 
instrument to quantitate migration (Varani et al., 
1978; Nabeshima et al., 1986; Fliegel et al., 1985; 
1986; Wewer et al., 1987). Membrane invasion culture 
system (MICS) chambers, (Gehlsen et al., 1984), 
Transwell chambers (Repesh, 1989) and numerous 
other chambers that are modifications of the Boyden 
chamber have been used to evaluate migration and 
invasion. Early studies on quantitating migration in 
the Boyden chamber (Varani et al., 1978) have now 
evolved to analyze the effect on migration by various 
chemotactic agents (Orr et al., 1978; Lam et al., 
1981; Thorgeirsson et al., 1982; Varani et al., 1985), 
haptotaxic agents (McCarthy and Furcht, 1984; 
McCarthy et al., 1986) and drugs (Spiro and Mundy, 
1980; Daughaday et al., 1981). Light microscopy 
(Thorgeirsson et al., 1982), radiolabelling (Repesh, 
1989) and scanning electron microscopy (Albrecht-
Buehler, 1986) have been used to evaluate cell 
locomotion and migration. 
Agents that interfere with either microtubules 
(e.g., colchicine or taxol) or microfilaments (e.g., 
cytochalasin B) inhibit tumor cell migration ( Spiro 
and Mundy, 1980). Raz and Geiger (1982) speculated 
that the role of the cytoskeleton was not only active 
in migration, but also in the tumor cell's ability to 
deform and make/break intercellular contact. Reti-
noic acid (RA) and butyric acid (BA) inhibit growth 
and induce differentiation of tumor cells ( Nordenberg 
et al., 1986; Roberts and Sporn, 1984) as well as af-
fect the cytoskeleton (Lehtonen et al., 1983; Ng et 
al., 1985; Borenfreund et al., 1980). 
In our investigation, we quantitated by scanning 
electron microscopy ( SE M) the migration of 
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untreated, RA-treated, and BA-treated B16a cells 
through porous polycarbonate membranes. We calcu-
lated migration rates by SEM. The migration rate of 
B16a cells was defined as the number of cells adher-
ing to the bottom of a polycarbonate membrane di-
vided by the number of cells plated. The number of 
cells adhering to the bottom of the entire membrane 
was extrapolated from the number of cells counted 
within 50 random fields as observed by SEM. This 
study demonstrated that RA inhibited while BA in-
creased the migration rate of B16a cells. We have 
also shown by transmission electron microscopy 
(TEM) that RA and BA induce changes in the cyto-
skeleton of B16a cells. The role of the cytoskeleton 
in tumor cell migration is discussed. 
Materials and Methods 
Cell Culture 
Mur1ne B16a (amelanotic) melanoma cells, also 
referred to as B16-F10a cells, were obtained from 
the DCT Tumor Repository (NCI Frederick Cancer 
Research Facility, Frederick, Maryland). Cells were 
cultured in Eagle's Minimum Essential Medium (MEM) 
(Gibco, Grand Island, NY) containing Hank's salts and 
1-glutamine supplemented with sodium pyruvate 
(Sigma, St. Louis, MO), 10% non-heat inactivated 
fetal calf serum (FCS) (Gibco), 1% penicillin G-
streptomycin sulfate-amphotericin B (Fungizone) 
(Gibco), MEM non-essential amino acids (Gibco), so-
dium bicarbonate (Sigma), and Hep es (Sigma). The 
final pH of the medium was 7. 3. Cells were cul tu red 
in a humidified incubator (37°C in 5% CO2) and were 
refed every three days. Cells were subcultured with 
trypsin/EDTA (Sigma) during the log phase of 
growth. All other parameters were standard. The 
tail vein experimental metastatic assay of Poste et 
al. (1980) was used to verify the lung-colonizing 
potential of the cells in C57BL6 mice. The meta-
static potential of the cells was confirmed prior to 
initiating the migration assays and also after 
completing all assays. 
In Vitro Growth Curves of RA, BA, Calf Serum, and 
Colch1cme-Treated Cells 
Cells were plated m triplicate for each experi-
ment at a concentration of 150,000 cells per 35 mm 
dish (50,000 cells per ml). 24 h later, RA (OM, 
10-8M, 10-7M, 10-6M and 10-5M in complete medium 
containing 0.1% ethanol), BA (0.0mM, 0.lmM, 0.2mM, 
0.5mM, lmM, 1.5mM and 2mM in phosphate buffered 
saline), 10% calf serum (CS), and colchicine (OM, 
10-8M, 10-7M and 10-5M in complete medium con-
taining 0.1% ethanol) were added independently. Re-
tinoic acid and colchicine were obtained from Sigma, 
BA from J. T. Baker (Phillipsburg, N .J.) and CS from 
Gibco. Different concentrations of RA were prepared 
under minimal light conditions according to the me-
thod of Lotan and Nicolson (1979). Retinoic acid 
was dissolved in 100% ethanol to produce a series of 
stock solutions from 10-l to 10-5 M, and stored for 
up to a week at -60°C. Stock solutions were diluted 
1: 1000 with complete medium prior to usage. Two 
sets of controls were run. One control contained 
complete medium. The second control contained 0 .1 % 
ethanol (the final ethanol concentration) in complete 
medium. The FCS was exposed to ultraviolet light 
for 1 h in order to destroy vitamin A activity ( Ng et 
al., 1985). The concentration of RA in the control 
medium was therefore considered to be 0 M. The 
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10-5M concentration of taxol used in the migration 
assay was the same concentration used in the motil-
ity assay of Keller and Zimmermann (1986). Viability 
and cell number were determined at 72 h by the try-
pan blue dye exclusion test and the hemacytometer, 
respectively. 
Incorporation of 3H Thymidine by BA-treated Cells 
The incorporation of 3H-thymidine was deter-
mined by autoradiography and beta scintillation 
according to the method of Ryan et al. (1987). For 
autoradiography, untreated and BA-treated (1.5 mM) 
were incubated for 72 hon acid-washed glass slides. 
One µCi/ml of 3H-thymidine (specific activity 6. 7 
Ci/mM) was added 24 and 54 h after the start of in-
cubation. Slides were washed with cold 0 .1 M 
thymidine in phosphate buffered saline (PBS) and 
fixed for 2 min at room temperature in freshly 
prepared 4% paraformaldehyde in PBS (pH=7 .4). 
Slides with unlabelled cells were run as a control. 
Slides were washed with PBS, dehydrated in ethanol 
and air dried. They were coated with Kodak NTB2 
emulsion, dried overnight in the dark, placed in a 
light tight box and refrigerated for 2, 4, and 6 days. 
Slides were developed in D19 developer for 5 min. 
Each slide was rinsed in 1 % acetic acid ( 30-60 sec) 
and fixed. Finally, slides were rinsed in running 
water and stained with Giemsa (Fisher Diagnostics, 
Orangeburg, NY). Analysis of 3H-thymidine incorpo-
ration for autoradiography was done by (1) counting 
the number of labelled and unlabelled cells, and (2) 
measuring the percent area of labelling in cells using 
a PGT digitizer. Background was defined as ~ 25 
grains/window on the PGT digitizer at a total m!)g-
nification of 1550X. The total incorporation of 3H-
thymidine using beta scintillation was determined as 
follows. Control and growth inhibitory concentra-
tions of BA were added in triplicate 24 h after cell 
plating. After 54 h, 1 or 2 µCi/ml of 3H-thymidine 
was added for 18 h. Cells were washed with Hank's 
Balanced Salt Solution (HBSS) without ca++ or Mg++ 
and lifted by trypsin/EDTA. Collected cells were 
either harvested onto glass filter paper or not fil -
tered. Aqueous scintillation fluor (Packard Instru-
ment Co., Inc., Downers Grove, IL) was added to the 
filters and to the unfiltered cell suspensions. Counts 
per minute were determined by liquid scintillation 
spectrophotometry. 
Incorporation of 3H-IdUR by RA-treated Cells 
The mcorporat1on of 3H-IdUR was determined 
by autoradiography and beta scintillation as in the 
above section with the following exceptions: ( 1) for 
both autoradiography and beta scintillation one 
µCi/ml of 3H-5-Iodo-deoxyuridine (Amersham Inc., 
Arlington Hts., IL) (specific activity of 5 Ci/mM) was 
added at 54 h after the start of incubation; (2) the 
cytostatic concentration of RA was used for both 
autoradiography and beta scintillation; ( 3) analysis of 
incorporation of 3H-IdUR by autoradiography was 
done only by counting labelled and unlabelled cells; 
and (4)cellular suspensions were filtered for beta 
scintillation. 
Migration Assay 
The methodology in this investigation was a 
modification of the migration assay of Varani et al. 
(1978). We utilized either the Transwell chamber 
system (Costar, Cambridge, MA) or a diffusion 
chamber (Persky and Grganto, 1987). Transwell 
chambers have a well within a well design containing 
a 3 or 5 µm diameter pore polycarbonate membrane 
In Vitro Migration of Bl6a Cells 
(10 µm in thickness) in the inner well. 
Trial 1 In the first investigation, polyc arbon -
ate membranes with 3 µm pores were utilized. Cells 
were plated at least in triplicate in the upper wells 
of the Transwell chambers (70,000 cells/well; 50,000 
cells/well; and 5,000 cells/well). Cells were allowed 
to attach to the polycarbonate membranes for 24 h 
prior to treatment with cytostatic concentrations of 
RA, BA, colchicine, or taxol. Cells were then incu-
bated for three days without refeeding. Drugs were 
not replenished during the migration assays. Cyto-
stasis was defined as the concentration of drug that 
inhibited cell growth without measurable cell death. 
The experiment in which cells were treated with or 
without BA (50,000 cells/well) was quantitated by 
SEM (n=4, 500X). The percent migration was deter-
mined from the number of cells counted/field times 
50 (the number of fields counted) times 15.36 (50 
fields at 500X is equal to 1/15.36 of the total sur-
face area). Colchicine, RA, and taxol-treated cells 
were qualitatively examined. 
Trials 2 - 4 In the second investigation, 
quantification of migration by SEM was done using 5 
µm diameter pore polycarbonate membranes (Nucle-
pore, Pleasanton, CA) in diffusion chambers or 5 µm 
pore Transwell chambers. Migration was evaluated 
by counting cells on the bottom surface of the mem-
branes after 18 (Trial 4) and 72 h (Trials 2 and 3) of 
incubation. The number of migratory cells was de-
termined by counting cells within 50 fields per mem-
brane, each field at 1, 700X. This magnification was 
selected in order to properly delineate cell bound-
aries. Percent migration was determined by two dif-
ferent methods. The first method was defined as the 
number of migratory cells counted per field times 50 
(the number of fields counted) times 177 .59 (50 fields 
at 1700X is equal to 1/177.56 of the total surface 
area) divided by 50,000 (the number of cells original-
ly plated). For the 18 h time period, untreated and 
BA-treated early passage (less than six passages) 
cells were plated into Tran swell chambers (50,000 
cells/well). For the 72 h time period, untreated, BA-
treated, BA-pretreated (72 h before plating), RA-
treated, and calf serum-treated early passage (Trial 
2) cells were plated into either the Transwell system 
or a diffusion chamber (50,000 cells/well). The sec-
ond methodology for determining percent of migra-
tion was calculated only for untreated and BA-
treated cells by incorporating a proliferation factor, 
Pf, for cellular proliferation in 35 mm dishes during 
the 3 day incubation period. The two Pf values were 
obtained with a hemacytometer by counting the num-
ber of untreated and BA-treated cells after 3 days of 
incubation. The Pf values were 777,275 and 177,500 
for untreated and BA-treated cells, respectively. 
This method was thus defined as the number of cells 
per 1, 700X field times 50 divided by Pf. 
Trial 3 Quantification of migration was done 
on later passage B16a cells (greater than 6 passages). 
Untreated, BA-treated, and BA-pretreated (72 h be-
fore plating) cells were plated into a Transwell 
chamber (n=4, 50,000 cells/well). 
Scanning Electron Microscopy 
All membranes were prepared according to 
standard techniques except that the membranes were 
air dried instead of critical point dried. Briefly, 
membranes were washed in 0.2M cacodylate buffer, 
fixed in 2% glutaraldehyde, and post fixed in 1% 
osmium tetroxide. The membranes were dehydrated, 
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air dried, mounted, and sputter coated with gold (27 
nm coating; Polaron ESl00 Series II sputter coater). 
Membranes were viewed with a JEOL JSM-840A SEM. 
Transmission Electron Microscopy (TEM) 
A prehmmary ultrastructural study was under-
taken to provide evidence that RA and BA modify 
the cytoskeleton of B16a cells. Transmission elec-
tron microscopy was done according to the method 
of McDonald (1984) and Costar Corporation (personal 
communication) in order to preserve microfilaments. 
Briefly, a migration assay was run with untreated, 
RA-pretreated, and BA-pretreated cells in Transwell 
chambers. All steps were run with membranes still 
in the Transwell chambers. Membranes were fixed 
after 72 h with 2% glutaraldehyde in 50 mM cacodyl-
ate buffer (pH=7 .4) containing 5 mM CaCl2 for 30 
min at 37°C. The membranes were rinsed in buffer 
(3X) for 5 min at 37°C and incubated in buffer con-
taining 0.8% K3Fe(CN)5 for 30 min. The membranes 
were incubated in buffer containing O .5 % OsO4 and 
0 .8% K3Fe(CN)5 for 30 min, rinsed in buffer, and 
then rinsed in distilled water (3X). The membranes 
were stained en bloc with 2% uranyl acetate (distilled 
water) for 60 to 120 min, rinsed in distilled water 
(3X) and then dehydrated in grades of ethanol. 
Membranes were infiltrated into resin (Epon-
Araldite), cut out of the Transwell inner well, and 
polymerized in blocks at 60°C for several days. Thin 
sections were cut, stained in 1 % uranyl acetate (in 
70% methanol) and lead citrate, and viewed with a 
Hitachi H-600 transmission electron microscope. 
Results 
Growth Curves 
In vitro growth curves of BA (Fig. 1), RA (Fig. 
2), ana colchicine-treated (Fig. 3) cells were deter-
mined by hemacytometer. Cell viability for the six 
different treatment groups (control medium, control 
medium + 0.1% ethanol, RA, CS, BA, and colchicine) 
as determined by the trypan blue exclusion test was 
always greater than 90%. 
Cells were treated for 72 h with different con-
centrations of BA (Fig. 1). A concentration 2 mM 
BA was found to be cytotoxic as fewer cells were 
found after 72 h (130,500 ± 33,600) than were plated 
(150,000). A concentration of 1.5 mM BA was not 
cytotoxic yet inhibited proliferation by 77% ± 6% as 
compared to the controls (0 mM). After 72 h of in-
cubation in 1.5 mM BA, viability was comparable to 
72 h controls (0 mM), i.e., 97.3% ± 1.5% and 98.9% ± 
0. 3 % , respectively. The 'cytostatic 'concentration of 
BA was determined to be 1.5 mM and was used for 
all further cell proliferation and migration experi-
ments. It was also observed that the lowest concen-
tration of BA (0.lmM) inhibited proliferation by 35%. 
The cytotoxic/ cytostatic concentrations for RA 
were determined to be 1 X 10-5 M/1 X 10-6 M, re-
spectively (Fig. 2). The cytostatic concentration in-
hibited proliferation as compared to the O .1 % ethanol 
control by 65% and was used for all further cell pro-
liferation and migration experiments. The lowest 
concentration tested (1 X 10-8 M) inhibited prolifer-
ation by 50%. The dishes that contained 1 X 10-4 M 
concentration of RA were found to have more viable 
cells than 1 X 10-7 M. Since crystals of RA were 
found in the 1 X 10-4 M concentration medium, we 
believe that this concentration produced a super-
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Number of BA-treated B16a Cells 
•··•··•···· ·· ·•··. 
Figures 1-3 (to the left). Dose response curves as 
measured by hemacytometer for BA, RA, and colchi-
cine-treated B16a cells. Cells were plated (50,000 
cells/ml, 3 ml total) in culture dishes. Various con-
centrations of BA, RA, and colchicine were added 
after 24 h. Cell number was determined 96 h after 
plating. Dotted line indicates number of cells plated. 
completely dissolve in ethanol. The addition of O .1 % 
ethanol did not affect proliferation (p < 0.05) (Table 
1). Proliferation was significantly inhibited (p < 
0.001) by 59.1% when 10% CS was substituted for 10% 
fetal calf serum (Table 1). 
Figure 3 is the growth curve of colchicine-
treated cells. The cytostatic concentration was 
determined to be 5 X 10-7 M. 
3H-Thymidine Incorporation in BA-treated Cells 
o+---o-t.-
0
-o+. 2-0-t.-.-o+. s-o-t.-e-,+. o-,--+.-2-,-+-.• ,--+.-6 -, +-. e----:2---t. o~ 
BA cone. (mMl 
Inhibition of 3H -thymidine incorporation by BA 
was determined by autoradiography and beta scintil-
lation. In the experiments using autoradiography, 
two different 3H-thymidine incubation times, 18 h 
and 48 h, were used. Two separate experiments were 
done in which the cells were labelled for 18 h, 
starting 54 h after cell plating. Unlabelled and la-
belled cells were counted from twelve different fields 
(average of 125 cells counted/field, 200X) from three 
different slides (two slides from the first 18 h proto-
col, one from the second 18 h protocol). Autoradio-
graphy revealed that after 18 h 59.1% (standard error 
of mean, SE = 9.3) of the untreated cells had incor-
porated the 3H-thymidine, while only 32.9% (SE = 
0.6) of the BA-treated cells had incorporated the 
label. The percent inhibition of 3H-thymidine 
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Number of Colchicine-treated B16a Cells 
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Two autoradiography methods (A and B) were 
used for counting cells that were labelled with 3H-
thymidine for 48 h. For both methods, cells were 
labelled 24 h after plating. For method A, the abso-
lute number of labelled and unlabelled cells was 
counted. After 48 h of incubation, 96% of the 
untreated cells were labelled, while 58.5% of the BA-
treated cells were labelled (data not shown). The 
percent inhibition of incorporation of 3H-thymidine 
was calculated to be 39.1%. For method B, the 
amount of labelling was calculated on a PGT digitizer 
from the percent of a set area containing the label 
(739.8 µm2, 689X). A total of 53 cells were digitized 
for each group, i.e., untreated and BA-treated cells. 
A minimum of 10 random fields were investigated for 
each group. The area labelled in untreated and BA-
treated cells was calculated to be 6.6% (S.D. = 3.2) 
and 3.2% (S.D. = 3.7), respectively. The percent 
areas were significantly different (p < 0.0001). 
Lastly, 3H-thymidine incorporation for untreated 
and BA-treated cells was measured after an 18 h in-
cubation period by beta scintillation. The average 
percent inhibition of 3H-thymidine incorporation was 
80% (Table 2). 
3H-ldUR Incorporation in RA-treated Cells 
Inhibition of 3H-ldUR incorporation by RA was 
determined by autoradiography and beta scintillation. 
For the autoradiography, unlabelled and labelled cells 
were counted from 21 (untreated) or 24 (RA-treated) 
different fields (200X) from three different slides. 
Autoradiography revealed that 64.5% (SE = 1.58) of 
the untreated cells were labelled after 18 h incuba-
tion with 3H-ldUR, while only 29.8% (SE = 1.47) of 
the RA-treated cells had incorporated the label. The 
percent inhibition of 3H-ldUR was calculated to be 
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In Vitro Migration of Bl6a Cells 




















Table 1. The means of the untreated and O .1 % ethanol groups were not significantly different (p > 0. 05). The 
means of the hemacytometer counts for 10% FCS-treated cells and 10% CS-treated cells were significantly dif-
ferent (p < 0.001). 






















Table 2. The 3tt-thymidine incorporation by untreated and BA-treated cells after 18 h incubation was 
measured. Cells were lifted with trypsin/EDTA. Filtered cell suspensions were collected with a cell 
harvester. The percent inhibition by BA of 3tt-thymidine incorporation was 67 .9% for unfiltered cell 
suspensions and 93 .1 % for filtered cell suspensions. The average percent inhibition was 80%. 
TABLE 3 INCORPORATION OF 3tt-IdUR CPM AS 












Table 3. The 3tt-IdUR incorporation by untreated 
and RA-treated cells after 18 h incubation was meas-
ured. Cell were lifted with trypsin/EDTA and the 
cell suspension was filtered with a cell harvester. 
The percent inhibition of 3tt-IdUR incorporation by 
RA was 72 .3%. 
52 .6%. For the beta scintillation, the percent inhi-
bition of 3tt-IdUR incorporation was 72.3% (Table 3). 
Migration Assay 
The 1mhal experiments using 3 µm diameter 
pore polycarbonate membranes led to further analysis 
and quantification of migration with 5 µm diameter 
pore membranes. Light microscopy showed untreated 
cells grown on plastic to be heterogeneous in mor-
phology (round to flat) as well as diverse in cell 
size. In contrast, BA-treated cells were a homoge-
neous population of large, flattened cells. 
The morphology of untreated cells (Figs. 4 and 
5), RA-treated (Fig. 6), BA-treated (Fig. 7), colchi-
cine-treated (Fig. 8) and taxol-treated (Fig. 9) cells 
was also evaluated by SEM on both 3 and 5 µm dia-
meter pore polycarbonate membranes. In all cases, 
cells on the top surface of the polycarbonate mem-
branes had morphology similar to comparable treated 
cells grown on plastic. Butyric acid (Fig. 7), colchi-
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cine (Fig. 8), and taxol (Fig. 9) treatment induced a 
flattened morphology as compared to untreated cells 
whether the cells were grown on plastic or on poly-
carbonate membranes. Colchicine and taxol-treated 
B16a cells on top of the membrane were not as flat-
tened in shape as BA-treated cells. The majority of 
colchicine (Fig. 8) and taxol treated cells (Fig. 9) 
were covered with blebs. Retinoic acid induced a 
spindle-shaped morphology. The major observation 
was that many more BA-treated cells migrated 
through 3 µm pore membranes than untreated, RA, 
colchicine, or taxol-treated cells. The experiment in 
which cells were treated with or without BA (50,000 
cells/well) was quantitated using SEM. The increase 
in the percent migration induced by BA over un-
treated controls was calculated to be 511% (Trial 1, 
Table 4). Migration through the membrane for un-
treated (Fig. 4), RA-treated, colchicine (Fig. 8) or 
taxol (Fig. 9) was < 2% of the original plated num-
ber. Cell plating density, which ranged from 5,000 
to 75,000 cells per well, did not have an effect on 
the migration of untreated and BA-treated cells 
through the 3 µm pore polycarbonate membrane (data 
not shown). 
Later experiments quantitated by SEM the mi-
gration of untreated and treated cells through 5 µm 
pore diameter membranes after 18 (Trial 4, Table 4) 
and 72 h (Trials 2 and 3, Table 4) of incubation. 
Both diffusion chambers and Transwell chambers were 
used. Table 4 illustrates that Transwell chambers 
were used for Trials 3, 4, and PBA, RA, CS treat-
ments of Trial 2. Diffusion chambers were used for 
the other parameters of Trial 2. 
Trial 2 Using early passage cells (passage 
less than six), an average of 3 .11 control cells/field 
( SE = 1.2 2) and 3. 23 BA-treated cells/field ( SE = 
1.13) were observed on the bottom of the membrane 
T. W. Mc Garvey and B. Persky 
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Figure 4 (at left). Scanning electron micrograph of 
untreated cell on the top surface of a 3 µm pore 
polycarbonate membrane after 72 h of incubation. 
Figures 5-7 (below and facing page top). Scanning 
electron m1crographs of untreated (Fig. 5), RA-
treated (Fig. 6), and BA-pretreated (Fig. 7) cells on 
the top ("a") and bottom ("b") surfaces of 5 µm dia-
meter pore polycarbonate membranes after 72 h of 
incubation. Note the pseudopod coming out of a 
pore in Figures 5 and 6 (arrow). 
Figures 8-9 (facing page middle). Scanning electron 
m1crographs of colchicine and taxol-treated cells on 
the top surface of 5 µm diameter pore polycarbonate 
membranes after 72 h of incubation. 
Bars = 10 µm for Figures 4 to 9. 
In Vitro Migration of Bl6a Cells 
(Table 4). The number of cells per field initially 
suggest no significant difference in migration be-
tween untreated and BA-treated cells. However, 
these numbers do not take into account the partial 
cytostasis induced by BA. If migration rates were 
formulated to incorporate cellular proliferation (Fig. 
1) during a three day incubation period, BA-treat-
ment enhanced migration by 456% over controls (p < 
0.015) (Table 5). The migration of BA-treated cells 
using 10% FCS was 192% greater than untreated cells 
using 10% calf serum (p < 0.04) (Trial 2, Table 4). 
A further enhancement of migration was induced by 
BA if cells were pretreated for 72 h with BA before 
plating. Pretreatment increased migration over non-
pretreated BA-treated cells by 196% (p < 0.005) and 
similarly increased migration over untreated cells by 
403% (p < 0.02) (Trial 2, Table 4). If 72 h migration 
rates were formulated to incorporate proliferation, 
the rate for the BA pretreated cells was 893% (p < 
0. 001) greater than untreated cells (Table 5). There 
was no significant difference in migration in the 18 
h incubation period between untreated and BA-
treated cells (Trial 4, Table 4). In contrast, the 
migration of RA-treated cells during the 72 h incu-
bation period was decreased by 75% (p < 0.03) as 
compared to untreated cells, and decreased by 53% 
compared to cells treated with calf serum (p < 0.005) 
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(Trial 2, Table 4). The level of significance between 
the migration rates of 10% CS-treated cells and 10% 
FCS-treated (CO) cells was p < 0.1. 
Trial 3 Migration was quantified using later 
passage B16a cells. The methodology above was used 
to quantitate migration of untreated, BA-treated, and 
PBA-treated cells (n = 4). The percent migration of 
untreated cells was calculated to be 3. 72% of the 
plated number. Again, we found that BA or PBA in-
creased migration by 438% and 919%, respectively, 
over the untreated controls (p < 0.03, p < 0.005). 
Transmission Electron Microscopy 
The analysis of the cytoskeleton of untreated, 
RA-treated and BA-treated B16a cells was a qualita-
tive TEM study. Analysis of untreated B16a cells 
found two distinct cytoskeletal phenotypes. Cells 
that were not visibly attached to the substrate dis-
played few microtubules and intermediate filaments. 
Microfilaments were visible only along cell margins. 
Cells that were attached to the substrate displayed a 
disorganized microtubule and intermediate filament 
system. Microfilaments were found in the cortical 
areas of the cytoplasm (Fig. 10). In contrast to 
untreated cells, RA and BA treatment altered the 
structure of the cytoskeleton. Retinoic acid-treated 
cells displayed parallel arrays of microtubules and 
intermediate filaments (Fig. 11). Less cortical 
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• The 1700x magnification was used to delineate cell boundaries. Care was taken not to overlap between cells. 
" Refer to proliferation table, Table 5. 
"' N.S. = not significant. 
Table 4. The migration of B16a through 3 µm and 5 µm diameter pore polycarbonate membranes. There was 
a sigmficant difference in the migration through a 3 µm diameter pore membrane between untreated and BA-
treated cells (p < 0.013) (Trial 1). In contrast, there was no significant difference between untreated and 
BA-treated early passage cells (Trial 2), but there was a significant difference between untreated and BA-
treated late passage cells after 72 h incubation (Trial 3). Interestingly, there was a significant increase in 
migration of BA-pretreated early passage cells as compared to control and BA-treated cells (p < 0. 02, p < 
0.005 respectively, Trial 2). There was also a significant decrease in migration of RA-treated cells as com-
pared to control and calf serum-treated cells (p < 0.03, p < 0.005 respectively). Lastly, there was no signifi-
cant difference between untreated and BA-treated cells after 18 h incubation. This table includes percent mi-
gration and percent change in migration. The percent change in migration of untreated cells was considered 
to be 100%. 
Sample Number Control (CO) Butyrate (BA) Pre-butyrate (PBA) 
1 0 .000380 0.001830 0 .001630 
2 0.000122 0 .000490 0 .001980 
3 0.000185 0 .000500 0.001770 
4 0.000257 0.000750 0.001740 
5 0.000053 0.001008 0.001770 
6 0.000873 
N 5 6 5 
X 0.000199 0.000908 0.001778 
SD 0.000126 0 .000495 0.000127 
SE 0.000056 0.000020 0.000057 
% mig. 100 456 893 
Table 5. The migration of control, BA-treated, and BA-pretreated cells after 72 h incubation with a prolifer-
ation factor incorporated into the migration rate. The migration value was defined as the number of cells per 
field times 50 divided by the final hemacytometer cell population after 72 h incubation (Fig. 1). There was a 
significant increase in migration of BA-treated and BA-pretreated cells as compared to control cells (p < 
0.015, p < 0.001, respectively). 
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In Vitro Migration of Bl6a Cells 
microfilaments were seen with wider focal adhesion 
contacts than in untreated cells. Butyric acid-
treated cells also displayed parallel arrays of micro-
tubules and intermediate filaments oriented along the 
longitudinal axis of the cells. An extensive cortical 
microfilament network was also seen (Fig. 12). This 
preliminary ultrastructural study supports the evi-
dence presented in the literature that RA and BA 
alter the structure of the cytoskeleton. 
Discussion 
In this investigation, BA enhanced while RA de-
creased the migration of B16a cells through 3 and 5 
µm diameter pores. Migration of untreated and RA-
treated cells through 3 µm pore membranes was neg-
ligible ( < 2% of cells plated). In contrast to un-
treated cells, treatment with BA resulted in a 511% 
increase in migration through 3 µm diameter pores. 
The 3 µm diameter pore is near the minimum 1 - 2 
µm pore size that allows passage of B16 cells 
Figure 10-12. Transmission electron micrographs of 
untreated (Fig. 10), RA-treated (Fig. 11), and BA-
treated cells (Fig. 12). The untreated cell (Fig. 10) 
displays a disorganized microtubule and intermediate 
filament system with microfilaments in the cortical 
area of the cytoplasm. The RA-treated cell (Fig. 11) 
shows an organized microtubule and intermediate 
filament system with less cortical actin than un-
treated cells. The BA-treated cell (Fig. 12) displays 
an extensive system of parallel microtubules and a 
large amount of cortical actin. (Bar = 0 .5 µm). 
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(Tullberg and Burger, 1985). Untreated early passage 
(less than 6 passages) cells migrated significantly 
through 5 µm diameter pores ( 55 .1 % ) . The effect of 
BA on the percent change of migration through 5 
µm pores was not as pronounced as through 3 µm 
diameter pores (104% vs 511% migration, respective-
ly). On the other hand, RA-treated cells migrated 
through 5 µm pores at 14.0%, i.e., 75% less than un-
treated cells. 
It was important to determine the cytotoxic/cy-
tostatic concentrations of RA and BA since they vary 
from cell line to cell line (Reese et al., 1985; 
Kyritsis et al., 1984; Lotan and Nicolson, 1979). The 
use of non-cytotoxic drug concentrations in in vitro 
migration assays is important since cytotoxicTiy will 
mask enhancement or inhibition of migration ( Mareel 
and DeMets, 1984). We used hemacytometer counts 
to demonstrate that RA and BA decreased prolifera-
tion during the three day incubation period. We 
used autoradiography and beta scintillation to show 
that RA and BA also inhibited the incorporation of 
3H-thymidine and 3H-ld UR. Both RA and BA have 
been shown to inhibit proliferation in various tumor 
cell lines in the Gl phase of the cell cycle (Roberts 
and Sporn, 1984; Thorgeirsson et al., 1984). 
In our study, phase microscopy and SE M re-
vealed morphological changes in RA and BA-treated 
cells. How these changes are related to migration is 
not known. The untreated cell population on top of 
3 and 5 µm pore membranes is heterogeneous (Figs. 
4 and 5a). There are, however, more flattened cells 
on top of 3 µm pore membranes than 5 µm pore 
membranes. Concomitantly, bottom surfaces of 5 µm 
pore membranes are dominated by flattened cells. 
We conclude that increasing the pore size from 3 to 
5 µm allowed more flattened cells to migrate to the 
bottom surface. Rounded-up cells, i.e., mitotic cells, 
do not migrate. It is therefore not surprising that 
incubation with BA, which enhances cell flattening, 
increases cell migration. The morphology of RA-
treated cells differs from either untreated or BA-
treated cells. The RA-treated cell population con-
sisted of spindle to flattened shaped cells. 
Various methods have been used to quantify 
motility (Volk et al., 1984; Keller and Zimmermann, 
1986), deformabilty (Ochalek et al., 1988) and to 
correlate these properties to metastatic potential. 
Methods used to quantify motility include time lapse 
photography (Keller and Zimmermann, 1986) and the 
phagokinetic assay (Volk et al., 1984). Data from 
the above experiments have in some cases been found 
to be in direct conflict with data from migration as-
says (Spiro and Mundy, 1980). Our experimental pro-
tocol emphasizes that migration incorporates both ac -
tive cellular deformabilty and motility (locomotion) 
(Daughaday et al., 1981). Migration is therefore 
defined as the net summation of cellular deformabili-
ty and motility. Microtubule (MT) inhibitors, e.g., 
colchicine, and microfilament (MF) disrupting agents, 
e.g., cytochalasin B, inhibited the migration of tumor 
cells in a micropore filter system (Spiro and Mundy, 
1980) even though cell motility was enhanced ( Keller 
and Zimmermann, 1986). The decreased migration 
seen with microtubule inhibitors may be due to re-
duced cellular deformability (Ochalek et al., 1988). 
Retinoic acid is not a microtubule inhibitor, so the 
decrease in migration of RA-treated cells may be due 
to its affecting motility rather than deformability. 
In contrast, since the percent increase in migration 
600 
of early passage BA-treated cells through the 3 µm 
diameter pore membrane is greater than through the 
5 µm pore membrane, BA may be affecting deforma-
bility rather than motility. 
Retinoic acid and BA are being investigated as 
potential antitumor-antimetastatic agents, Studies on 
various cell lines (Roberts and Sporn, 1984; 
Thorgeirsson et al., 1984; Ryan et al., 1987), includ-
ing the B16 melanoma cell line (Lotan and Nicolson, 
1979; Nordenberg et al., 1986) have stressed the ef-
fect of RA and BA on growth inhibition and differ-
entiation. The change in morphology in these cell 
lines has been linked to a change in the cytoskeleton 
(Lehtonen et al., 1983; Ng et al., 1985; Altenburg et 
al., 1976; Borenfreund et al., 1980). 
The role of the cytoskeleton in migration has 
been demonstrated by microtubule inhibitors (e.g., 
colchicine, vinblastine) and microfilament inhibitors 
(e.g., cytochalasin B) (Spiro and Mundy 1980). These 
inhibitors reduce migration. Both RA and BA have 
been shown in various tumor cell lines to increase 
the formation of microfilaments and vinculin plaques, 
and to reorganize vimentin intermediate filaments 
(Lehtonen et al., 1983; Ng et al., 1985; Altenburg et 
al., 1976; Borenfreund et al., 1980). We also ob-
served by TEM an increase in microtubule and micro-
filament organization in B16a cells. Retinoic acid 
and BA induced changes in the cytoskeleton appear 
to be similar, although the surface morphology and 
shape of RA or BA-treated cells differ as examined 
by phase contrast microscopy and SE M. Subtle 
changes in the cytoskeleton may induce migration of 
BA-treated cells while inhibiting the migration of 
RA-treated cells. Butyric acid may have a role in 
increasing the amount of acetylated a-tubulin (Grant 
et al., 1987) thus contributing to the stabilization of 
microtubules (Piperno et al., 1987). 
The role of cellular migration in invasion and 
metastasis needs further investigation. The Trans-
well system has merit for both migration and inva-
sion assays. Various investigators have studied inva-
sion by using porous polycarbonate membranes coated 
with a reconstituted basement membrane (Matrigel) 
(Albini et al., 1987; Hendrix et al., 1987; Repesh, 
1989). An increase in migration of tumor cells in 
vitro has been linked to enhanced invasion in vitro 
(Grlmstad, 1987; Verschueren et al., 1988). However, 
enhanced in vitro migration of tumor cells may not 
necessarily lead to increased metastasis. Grimstad 
(1988) found that hypermotile selected fibrosarcoma 
cells were less metastatic than the original parent 
population. Mohler et al. (1988) found, in contrast, 
a positive correlation between metastatic potential of 
Dunning R-3327 rat prostatic adenocarcinoma cells 
and motility. Invasive cells that form specialized 
pseudopodia have been interpreted by Kramer et al. 
(1986) to form adhesion contacts with the matrix. 
We observed that migratory cells (e.g., Fig. 5b) also 
form pseudopodia when passing through 5 µm diame-
ter pores. In addition, we have observed by TEM 
focal adhesion contacts (not illustrated). 
Cell motility has been linked to various parts of 
the cell cycle in 3T3 fibroblasts (Thurston and 
Palcic, 1987). Thurston and Palcic ( 1987) found a 
peak in the rate of cell movement in G2 and a sig-
nificant increase in the average rate of movement as 
cells transit from Gl to S phase. The significance 
of their data, which was obtained on 3T3 cells, as 
applied to a tumor cell system is not known. Since 
In Vitro Migration of Bl6a Cells 
RA and BA block entry into the S phase of the cell 
cycle (Roberts and Sporn, 1984; Thorgeirsson et al., 
1984), Thurston and Palcic's data may not be appli-
cable. Thurston and Palcic (1987) also found a weak 
correlation between the rate of cell motility and the 
rate of cell proliferation. It is extremely important 
to emphasize that a decrease in proliferation is not 
sufficient to explain an increase in migration of BA-
treated cells. A 5 X 10-5 M concentration of RA 
inhibits both proliferation and migration. Calf serum 
(CS) does not have as many of the growth factors 
that are in fetal calf serum. Calf serum was found 
to inhibit cell proliferation by 59.1% as compared to 
10% FCS (Table 1). The migration of CS-treated 
cells is also significantly decreased from the controls 
(p < 0.1) and BA-treated cells. The migration of 
calf serum-treated cells, however, is significantly 
greater than the RA-treated cells (P < 0.005). 
Therefore, we conclude that the decrease in migra-
tion produced by RA was due to both an inhibitory 
effect on cell migration and a decrease in prolifera-
tion. A purely speculative explanation for the anti-
migratory effect of RA is that changes in glycopro-
teins found on the cell surface may influence migra-
tion (Lotan et al., 1987 a,b; Couch et al., 1987, 
1988). 
The migration rates for untreated and BA-
treated early passage cells were similar (Table 4). 
However, if the decrease of cellular proliferation by 
BA is included in defining migration, the enhance-
ment of migration by BA is significant (Table 5). 
Hendrix et al. (1985) have stated that cells which 
invaded the amnion had similar proliferation rates as 
cells which did not invade. The observation that mi-
gration by preincubated BA-treated cells was signif-
icantly different from untreated and BA-treated cells 
suggests that further changes occur in the phenotype 
of these cells after 3 days. Tumor cell migration 
has been investigated in vitro using short time pe-
riods (4-18 h) (Varani el: aC;7.985; Nabeshima et al., 
1986; Grimstad, 1988). It is questionable whether 
four hours is long enough to quantitate migration in 
this or any other assay. Perhaps such a short period 
does not adequately reflect the in vivo condition. 
We noted that there was no sign1ficant difference 
between the migration of untreated and BA-treated 
cells at 18 h (even if 18 h proliferation data were 
used in the calculations, data not shown). Cells 
treated for 72 h with BA before plating show a sig-
nificant increase in migration (greater than both the 
untreated and BA-treated cells) in a three day assay 
(Tables 4 and 5). It would be of interest to pretreat 
cells with BA or RA for 72 h prior to an 18 h 
migration assay. 
In summary, RA and BA warranted investigation 
for two main reasons. First, these two drugs can be 
less host toxic and less mutagenic than conventional 
chemotherapeutic drugs when administered at cyto-
static concentrations. Second, the effects of RA and 
BA on the individual steps of the metastatic cascade 
are only beginning to be known. 
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Discussion with Reviewers 
R. Lotan: What is a diffusion chamber? 
Authors: Our diffusion chamber is a modification of 
the Membrane Invasion Culture System ( MICS) cham-
ber (Gehl sen et al., 1984; text reference). Figure 13 
is a 14 well MICS chamber. Our diffusion chamber 
is similar to the MICS chamber except that the dif-
fusion chamber has 45 wells. In the migration as-
says, complete medium with or without a drug is 
added to the lower wells. The polycarbonate mem-
brane is placed between an upper and lower chamber, 
creating 45 separate upper and lower wells. Cells 
are then added in complete medium, with or without 






Figure 13: MEMBRANE INVASION CULTURE SYSTEM 
(MICS; Pat Pending 84-027-1) 
(A) Top Plate; (B) Bottom Plate; 
(C and E) Upper Wells; (D and F) Lower Wells; 
( G) Polycarbonate Membrane; 
(H) Washer; (I) Bolt. 
(Redrawn with permission from Hendrix et al., 1985). 
M. J.C. Hendrix: It is very difficult to derive signifi-
cant statistical information from Table 4 when less 
than seven cells are presented? 
Authors: As a purely statistical question, this is a 
vahd criticism. Table 4 presents data obtained from 
50 fields at 1700X. Data could have been presented 
at lower magnifications, e.g., 500X. At 500X, the 
exact same quantitated surface area would have pro-
vided 15 fields (1,700 divided by 500 = 3.4; 50 divided 
by 3 .4 = 15). The mean number of cells for Table 4 
would therefore be 3.4X greater. We chose to pre-
sent the data at 1, 700X because we could positively 
distinguish individual cells at higher magnification. 
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R.Lotan: It would have been interesting if a low 
metastatic variant had been used in the migration 
assay. 
Authors: This is true, but the objectives of this 
project are to evaluate the effect of two drugs on a 
highly metastatic cell line. This project is part of 
an overall investigation that will evaluate the effect 
of RA and BA on viability, proliferation, migration, 
invasion, and metastasis. Since the human amnionic 
basement membrane (HABM) assay of Liotta et al. 
(New method for preparing large surfaces of intact 
human basement membrane for tumor invasion 
studies. Cancer Letters, 11: 141-152, 1980) is being 
used as one of the invasion assays, and since the 
HABM assay is only valid for highly invasive cells 
(Welch, DR. 1986, Discussion of the suitability, avail-
ability and requirements for in vivo and in vitro 
models of metastasis. In: Cancer Metastasis, Experi-
mental and Clinical Strategies; DR Welch, BK Bhuyan, 
and LA Liotta (eds.). Alan R. Liss, Inc., 135), low 
metastatic cells were not used. 
M.J .C. Hendrix: Is the rapid rate of biological de-
gradation of retinoic acid by tumor cells similar for 
butyric acid? If not, what bearing would this infor-
mation have on the data generated in this study? 
Authors: To our knowledge the rate of biological 
degradation of BA by tumor cells has not been re-
ported. The incorporation of tritiated RA by murine 
S91 melanoma cells has been reported to be rapid 
during the first 15 min. Tritiated RA is incorporated 
much more slowly after this initial 15 min time peri-
od (Lotan et al., Characterization of retinoic acid-
induced alterations in the proliferation and differen-
tiation of a murine and a human melanoma cell line 
in culture. Ann N.Y. Acad Sci 359: 150-170, 1981). 
In addition, S91 and B16 melanomacells, when grown 
in 10-5 M RA for six days and then refed in RA-free 
medium, continued to proliferate at a reduced rate 
for 24-48 h. However, after 3 days of incubation in 
RA-free medium, the growth rate of previously RA-
treated cells returned to that of the control cells 
( Lotan et al., Characterization of the inhibitory ef-
fects of retinoids on the vitro growth of two malig-
nant murine melanomas. JNCI 60: 1035-1041, 1980). 
This reversible inhibition of growth of various tumor 
cell lines has been reported by others using BA 
(Prasad and Sinha, Effect of sodium butyrate on 
mammalian cells in culture: a review. In Vitro 12: 
125-135, 1976). We have observed reversible changes 
in morphology of RA and BA-treated B16a cells after 
removal of the drug from the medium. Therefore, 
despite a rapid incorporation and rapid degradation 
of RA (and possibly BA) these drugs remain effective 
in changing morphology and inhibiting growth beyond 
the 72 h experimental time period. 
M.J.C. Hendrix: Was scanning electron microscopy 
the only techmque used to quantitate the tumor cells 
on the polycarbonate membranes? If so, what pre-
cautions were taken to insure that the entire filter 
was examined with SEM? Weren't the samples quite 
large to handle? 
Authors: Our initial attempts to quantitate cells by 
light microscopy were unsuccessful because we were 
not able to distinguish cells above, in, and below the 
membrane. Radioisotope labelling of cells was also 
attempted, but difficulties were encountered in 
removing BA-treated cells from the polycarbonate 
T. W. Mc Garvey and B. Persky 
membranes. Even a 20 min trypsin/EDTA incubation 
failed to completely remove the BA-treated cells 
from the membrane. The entire membrane was ob-
served by SEM. Care was taken to select 50 random 
fields to quantitate migration. Samples were not too 
large to handle. On the contrary the small size of 
the membranes permitted three complete Transwell 
membranes to be loaded at one time into the SEM. 
M.J .C. Hendrix: Do the authors propose that SEM 
offers a universal quantitation approach for tumor 
cell invasion that supersedes currently available 
technology? 
Authors: Scanning electron microscopy is an accu-
rate and reproducible method for quantifying migra-
tion and invasion. SEM allows visualization of top 
and bottom membrane surfaces and permits observa-
tion of individual cells. SEM does not have the 
depth of field resolution problem that is associated 
with light microscopy. SE M is but one method to 
quantitate cell invasion and migration. 
R. Lotan: Why is it probable that increasing the 
pore size from 3 µm to 5 µm allows "flattened" cells 
to migrate? 
Authors: We have shown that the migration of early 
passage untreated B16a cells through 5 µm diameter 
pore membranes is 66% greater than the migration 
through 3 µm diameter pore membranes (Trials 1 and 
3, Table 4). We have observed that cells on the top 
surface of the 3 µm diameter pore membrane are 
heterogeneous in shape and contain flattened cells. 
In contrast, the heterogeneous population of cells on 
top of 5 µm diameter pore membranes have few flat-
tened cells. It appears that the majority of cells on 
the bottom surface of the 5 µm pore membrane are 
flat in shape. 
R. Lotan: It is possible to dehydrate tissues for 
SEM with alcohol instead of acetone that would have 
allowed you to critical point dry the specimens in-
stead of air drying them. Also, the membranes can 
be cut out of the plastic well and processed 
separately. 
Authors: Despite the cracking produced by air dry-
ing, problems were not encountered in quantitating 
cells. The cracking produced by air drying the fil-
ters can be reduced by using hexamethyldisilazane 
(Nation et al. A new method using hexamethyldisila-
zane for preparation of soft insect tissues for scan-
ning electron microscopy. Stain Tech. 58: 347-351, 
1983). The membranes were processed in Transwell 
chambers to facilitate ease of handling. Cutting out 
the membranes prior to alcohol dehydration causes 
the membranes to roll up. 
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Reviewer IV: Is the rate of proliferation the same 
between cells grown on polycarbonate membranes as 
cells grown on tissue culture treated plastic? 
Authors: Yes. We have previously determined that 
there is no significant difference between B16a cell 
proliferation rates for cells grown on plastic dishes 
versus polycarbonate membranes. We quantified pro-
liferation by plating cells into Transwell chambers 
(50,000 cells/well) and into a 24 well plate (Corning) 
(50,000 cells/well). Each experiment was done in tri-
plicate and the number of cells determined after 72 
h by hemacytometer count. 
Reviewer IV: Why did the authors use two different 
radioisotopes to determine proliferation rates? 
Authors: After completing the BA experiments with 
3tt-thymidine, we changed radioisotopes to 3tt-IdUR. 
The irreversible binding property of 3tt-IdUR makes 
it a better radiolabel than 3tt-thymidine (Fidler, I. 
Metastasis: quantitative analysis of distribution and 
fate of tumor emboli labelled with 125I-5-Iodo-2' -
deoxyuridine. JNCI, 45: 773-782, 1971). Since BA had 
already been ghown to produce a significant inhibi-
tion of 3tt-thymidine incorporation, we thought it 
would not be necessary to repeat the BA experiments 
using 3tt-IdUR. 
Reviewer IV: The methodology of choice for deter-
mmmg cytotoxic/ cytostatic effects of drugs is the 
double-label growth assay. Why did the authors not 
use this technique? 
Authors: We agree that the double label growth as-
say is a preferred method to quantitate viability and 
proliferation in drug studies. Although the trypan 
blue exclusion method is less sensitive, it did provide 
cytotoxic/cytostatic data that was statistically signif-
icant. 
